Brandenburg, Germany

Christian Friedrich

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovator Christian Friedrich: A Pioneer in Pharmaceutical Advancements

Introduction: Christian Friedrich, an inventive mind based in Brandenburg, Germany, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of four patents, he has dedicated his talents to the development of novel medicinal compounds that address a variety of medical conditions.

Latest Patents: Friedrich's latest patents focus on substituted indazoles, innovative compounds that have the potential to be used in various pharmaceutical applications. His work includes methods for their production, pharmaceutical preparations containing these substances, and the utilization of substituted indazoles for the treatment and prophylaxis of diseases. Particularly noteworthy is his focus on conditions such as endometriosis, rheumatoid arthritis, multiple sclerosis, and several other ailments, which reflects his commitment to improving patient outcomes.

Career Highlights: Currently affiliated with Bayer Pharma Aktiengesellschaft, Friedrich's work has garnered attention for its relevance to pressing public health issues. His innovative approach has positioned him as a key player in the pharmaceutical industry, working on targeted therapies that may alleviate the suffering caused by complex and chronic conditions.

Collaborations: Throughout his career, Christian Friedrich has collaborated with esteemed colleagues including Ulrich Bothe and Holger Siebeneicher. These partnerships have enabled him to expand his research and innovate effectively within the pharmaceutical domain, leading to significant advancements in drug development.

Conclusion: In summary, Christian Friedrich exemplifies the spirit of innovation through his contributions to the pharmaceutical industry. His patent portfolio showcases his dedication to creating effective treatments for a range of serious medical conditions. As he continues his work at Bayer Pharma Aktiengesellschaft, the impact of his research is poised to benefit countless individuals grappling with challenging health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…